Effective Regenerative Solutions
StemVive is a novel flowable regenerative cellular allograft product that contains mesenchymal stem cells from Wharton’s Jelly and Umbilical Cord Blood for the greatest cellular composition available to patients.
The amniotic connective tissue matrix includes elements such as: growth factors, lipids, proteins, carbohydrates, and other nutrients. These elements can help protect, cushion, lubricate, reduce inflammation, and assist the body in the healing and regeneration process. Through our groundbreaking proprietary processing system we are able to protect and preserve high levels of donor stem cells and viability per unit even after cryopreservation.
Stemii is a viable cellular biologic product designed for local delivery of powerful healing factors. Individual components have been shown to stimulate the growth of healthy new bone and other tissue.
As a regenerative medical therapeutic, Stemii augments the body’s own restorative mechanism. Physician and patient-reported outcomes regarding Stemii include accelerated injury healing with significant pain relief. The unique biologic structure of amniotic tissue in Stemii make it an ideal choice for homologous clinical use.
SAFETY AND EFFICACY
The entire process, from local procurement to in-house processing and storage, is carefully monitored to ensure the safest, purest, most bioactive products for patients. Our products have been used by over 60,000 patients with no reportable severe adverse events.
Rigorous in-house and third party testing confirm that our proprietary methods consistently yield not only viable cells but cells that maintain normal cellular function as demonstrated by their ability to grow healthy colony forming units (CFU) when plated post-thaw. This is yet another way that we raise the bar for regenerative products. In fact, our cells are 150 times more likely to form a colony compared to fresh stem cells from bone marrow. This is a remarkable achievement, allowing our customers to have the confidence of knowing they are providing their patients a superior product.
Our proprietary process begins with meticulous screening of the donor mother and father as well as family members for several generations. In addition to routine industry screens for blood borne pathogens, we also screen for heritable and non-heritable conditions, environmental contaminants from medications, alcohol, drugs, tobacco, and electronic vaping.
Only healthy families who meet or exceed these criteria are considered. Post-natal tissues are collected after Cesarean section. After processing, the allografts are tested again to ensure they are free of contaminants and infection and contain healthy, viable cells prior to cryopreservation.